LymeNet Home LymeNet Home Page LymeNet Flash Discussion LymeNet Support Group Database LymeNet Literature Library LymeNet Legal Resources LymeNet Medical & Scientific Abstract Database LymeNet Newsletter Home Page LymeNet Recommended Books LymeNet Tick Pictures Search The LymeNet Site LymeNet Links LymeNet Frequently Asked Questions About The Lyme Disease Network LymeNet Menu

LymeNet on Facebook

LymeNet on Twitter




The Lyme Disease Network receives a commission from Amazon.com for each purchase originating from this site.

When purchasing from Amazon.com, please
click here first.

Thank you.

LymeNet Flash Discussion
Dedicated to the Bachmann Family

LymeNet needs your help:
LymeNet 2020 fund drive


The Lyme Disease Network is a non-profit organization funded by individual donations.

LymeNet Flash Post New Topic  New Poll  Post A Reply
my profile | directory login | register | search | faq | forum home

  next oldest topic   next newest topic
» LymeNet Flash » Questions and Discussion » Activism » Lawmakers Sever Ties Between CDC And Big Pharma

 - UBBFriend: Email this page to someone!    
Author Topic: Lawmakers Sever Ties Between CDC And Big Pharma
Melanie Reber
Frequent Contributor (5K+ posts)
Member # 3707

Icon 4 posted      Profile for Melanie Reber   Author's Homepage         Edit/Delete Post   Reply With Quote 
"In June 2001, the General Accounting Office delivered a report on
the issue to Senator Chris Dodd, (D-Conn), that noted that CDC
employees "are listed on two Lyme-disease related patents"
including "a 1993 joint patent between CDC and SmithKline Beecham
Corporation." The report also said that six of 12 consultants
working for the CDC on Lyme vaccines "reported at least one interest
related to a vaccine firm."

"The government's database at the time, listed possible side effects
from LYMERIX as 640 emergency room visits, 34 life-threatening
reactions, 77 hospitalizations, 198 disabilities and six deaths
after people took the shots since the CDC endorsed it, according to
UPI."

LymeInfo Note: For more background on this subject, see
http://www.lymediseaseassociation.org/
Select "Conflicts of Interest" on the left

========

http://www.sierratimes.com/06/08/24/75_7_241_1_47489.htm

The Sierra Times
August 8, 2006

Lawmakers Sever Ties Between CDC And Big Pharma

Evelyn Pringle

In the wake of overhauling the FDA, lawmakers are also cracking down
on conflicts of interest within the Centers for Disease Control.
Last month, Representatives, Dr Dave Weldon (R-FL), and Carolyn
Maloney (D-NY), held a press conference to announce the introduction
of a bill that would give responsibility for vaccine safety to an
independent agency within the Department of Health and Human
Services, and remove most vaccine safety research from the CDC.

Specifically, they said on July 26, 2006, the "Vaccine Safety and
Public Confidence Assurance Act of 2006," will create an independent
office to address, investigate, and head off potential safety
problems like the use of mercury in vaccines, in an objective and
non-conflicted office whose sole purpose is vaccine safety and
evaluation.

According to Dr Weldon in a prepared statement, Federal agencies
charged with overseeing vaccine safety research have failed. They
have failed to provide sufficient resources for vaccine safety
research. They have failed to fund extramural research and they have
failed to free themselves from conflicts of interest that serve to
undermine public confidence in the safety of vaccines, he said.

"The American public deserves better," Dr Weldon stated, "and
increasingly parents and the public at large are demanding better."

"There's an enormous inherent conflict of interest within the CDC,"
he said, "and if we fail to move vaccine safety to a separate
independent office, safety issues will remain a low priority and
public confidence in vaccines will continue to erode."

He said that similar conflicts have been remedied in other federal
agencies, but in the vaccine program the conflicts persist
unchecked. "This bill will provide the independence necessary," Dr
Weldon said, "to ensure that vaccine safety research is robust,
unbiased, and broadly accepted by the public at large."

"Vaccines do wonders for public health, but when the government
requires them, it must also ensure that they're safe," Ms Maloney
said in her statement. "We need adequate, unbiased research on
vaccines, and this legislation would deliver that."

She applauded Dr Weldon for his tremendous commitment and leadership
on the issue. "He is truly dedicated," she said, "to protecting our
children and the public at large."

While announcing the new bill, Dr Weldon and Ms Maloney were joined
by several groups advocating vaccine safety reform, including the
National Autism Association, A-Champs, and safeMINDS.

According to the National Autism Association: "This landmark
legislation will provide critical government agency oversight and
implementation of vaccine safety research, which has not kept pace
with the rise in the number of vaccines routinely prescribed to
consumers including pregnant women and young children."

Additionally, the Act calls for $80 million in funding to conduct
vaccine analysis and safety research.

Currently the CDC oversees vaccine research, safety and promotion, a
situation that has been drawing more and more public criticism in
recent years. The CDC compiles the list of vaccines that doctors are
to give all children in the US, based on the recommendations of an
advisory panel, and in many states kids can not attend day care or
public schools unless they have received the CDC-endorsed vaccines.

A recommendation by the CDC guarantees a huge market for a vaccine
and enables the drug company to use the government as a marketing
device for its product. The annual global market for vaccines is
expected to be over $10 billion this year.

On July 21, 2003, United Press International published a report
based on a four-month investigation that found a pattern of problems
linked to vaccines recommended by the CDC, as well as a web of close
ties between the agency's advisory panel and the pharmaceutical
industry.

By investigating members of an advisory panel of outside experts
that make vaccine recommendations, UPI found that members of the
panel received money from vaccine makers through relationships that
included: sharing a vaccine patent; owning stock in a vaccine
company; payments for research; money to monitor vaccine testing;
and funding for academic departments.

In fact, according to UPI, the CDC itself is in the vaccine
business. Under a 1980 law, UPI found the CDC had 28 licensing
agreements with drug companies and one university for vaccines or
vaccine-related products and eight ongoing projects to collaborate
on new vaccines.

For instance, the CDC and SmithKline Beecham worked together on the
Lyme-disease vaccine. A 1992 CDC activity report, obtained by UPI,
says the agency had an agreement "with SmithKline Beecham that
currently funds three positions at (the CDC) for the purpose of
providing information of use in developing advanced test methods and
vaccine candidates."

In June 2001, the General Accounting Office delivered a report on
the issue to Senator Chris Dodd, (D-Conn), that noted that CDC
employees "are listed on two Lyme-disease related patents"
including "a 1993 joint patent between CDC and SmithKline Beecham
Corporation." The report also said that six of 12 consultants
working for the CDC on Lyme vaccines "reported at least one interest
related to a vaccine firm."

According to CDC meeting transcripts where the committee weighed its
recommendation, 3 had conflicts of interest with SmithKlineBeecham.
The LYMERIX lyme-disease vaccine was approved by the CDC on February
18, 1999, and by October of 2000, more than 1.4 million people had
received the vaccine.

But 18 months later, according to UPI, in February 2002, SmithKline
Beecham pulled the vaccine off the market claiming that sales of
LYMERIX were insufficient to justify the continued investment.
However, according to UPI, the company also faced hundreds of
lawsuits by people who said they suffered side effects from the
vaccines.

The government's database at the time, listed possible side effects
from LYMERIX as 640 emergency room visits, 34 life-threatening
reactions, 77 hospitalizations, 198 disabilities and six deaths
after people took the shots since the CDC endorsed it, according to
UPI.


UPI also found other cases where vaccines endorsed by the panel were
pulled off the market after a number of people suffered devastating
side effects, and some died.

Congressman Dan Burton, (R-Ind), had already been investigating the
advisory panel for several years, and told UPI that the conflicts of
interest were a major problem. "This presents a real paradox," he
said, "when the CDC routinely allows scientists with blatant
conflicts of interest to serve on influential advisory committees
that make recommendations on new vaccines, as well as policy
matters."

"All the while these same scientists," Representative Burton
said, "have financial ties, academic affiliations, and other vested
interests in the products and companies for which they are supposed
to be providing unbiased oversight."

An August 2001 report on the investigation by Rep. Burton's House
Government Reform Committee, stated that "four out of eight CDC
advisory committee members who voted to approve guidelines for the
rotavirus vaccine in June 1998 had financial ties to pharmaceutical
companies that were developing different versions of the vaccine."

Critic say the conflicts of interest of Dr Paul Offit while sitting
on the advisory panel could not be more blatant. He was part of the
team that mandated the use of the RotaVirus vaccine, even though he
received a $350,000 grant from Merck to develop the vaccine, shared
the patent, and was paid to go around the country teaching doctors
that vaccines were safe, according to the Wall Street Journal.

UPI discovered that Merck also had bought and distributed copies of
a book written by Dr Offit titled, "What Every Parent Should Know
About Vaccines," to physicians with a Dear Doctor letter that
stated:"Merck Vaccine Division is pleased to present you with a copy
of the recent publication, 'What Every Parent Should Know About
Vaccines.'"

"The authors designed the book," Merck's letter told doctors, "to
answer questions parents have about vaccines and to dispel
misinformation about vaccines that sometimes appears in the public
media."

The book had a list price of $14.95, and Dr Offit told UPI that he
did not know how many copies Merck had purchased.

In 2001, Congressman Burton's investigation also found conflicts of
interest with the then chairman of the advisory panel, Dr John
Modlin, a Professor at Dartmouth Medical School, who owned $26,000
worth of Merck stock.

In a phone interview in 2003, Dr Modlin told UPI that he had sold
the Merck stock, but that he had recently agreed to chair a
committee to oversee Merck vaccine clinical trials.

"Meeting transcripts over the past decade," UPI says, "showed that
at some meetings, half of the members present had potential
conflicts with vaccine manufacturers."

For instance, at a June 2002 meeting, four of the 11 members on the
panel acknowledged conflicts with Wyeth, GlaxoSmithKline, Merck,
Pfizer, Aventis Pasteur, and Bayer. Two of the four conducted
research or vaccine trials and one member was a co-holder of a

The agency is currently facing a major credibility crisis over the
issue of whether vaccines containing the mercury-based preservative,
thimerosal, are responsible for the epidemic of neurological
disorders ranging from ADHD to autism in children all across the
country.

The CDC is being accused of research manipulation and cover-ups of
vaccine maker culpability by an ever increasing number of activist
groups and is also facing tough questions from some of the powerful
members of Congress, both Republicans and Democrats alike.

The CDC continues to claim that there is no evidence to support a
connection between the epidemic and thimerosal, which they say is no
longer used in most pediatric vaccines. It is however, included in
the flu vaccine currently recommended for all pregnant women and
children more than 6 months old.

Earlier this year, a group of lawmakers initiated a new
investigation of the matter and basically directed the CDC to butt
out. On February 22, 2006, they stated in a letter: "If the federal
government is going to have a study whose results will be broadly
accepted, such a study cannot be led by the CDC," in a letter to Dr
David Schwartz, Director of the National Institute of Environmental
Health Sciences.

The letter was signed by Senators, Joe Lieberman (D-Conn) and Debbie
Stabenow (D-Mich), and members of the House Representatives
including, Dr Dave Weldon, (R-Fla) Chris Smith, (R-NJ), Carolyn
Maloney, (D-NY), Dan Burton, (R-Ind), Joseph Crowley, (D-NY), and
Maurice Hinchey, (D-NY).

The Institute of Environmental Health Sciences is part of the
National Institutes of Health, and was asked to convene a panel to
decide how to analyze the CDC database to determine whether autism
rates have dropped since thimerosal was removed from most vaccines.

The controversy picked up traction in April, "National Autism
Month," when world renowned heavy metal experts, researchers, and
physicians traveled to Washington and rallied on Capital Hill moving
the debate beyond just the parents of autistic children.

This spring, a full-page ad appeared in USA Today, the most widely-
circulated newspaper in the US, and accused the CDC of "causing an
epidemic of autism" by recommending that kids receive a series of
vaccinations that contained thimerosal at least as late as 2001.

The ad quoted one of the most recent and famous advocates to join
the cause, environmental lawyer, Robert F Kennedy Jr, as
saying: "It's time for the CDC to come clean with the American
public."

The ad was funded by a coalition of advocacy groups led by
Generation Rescue, and directed readers to the web site,
www.PutChildrenFirst.org, to view internal CDC documents, many of
which were obtained under the FOIA, that includes transcripts of
meetings and e-mails that the groups contend support their
allegations of a CDC cover-up.

Congressman Weldon has a theory about why the CDC continues the
charade of denying the link between vaccines and autism. "If it is
eventually determined that an entire generation of kids was
essentially poisoned," he says, "a class-action suit against the
federal government could be on the order of hundreds of billions of
dollars, and so there's very good reason for them to try to cover
this up."

And Dr Weldon's prediction is proving true. Vaccine injury lawsuits
are being filed and won against the vaccine makers and the
government. Implemented in 1988, the National Childhood Vaccine
Injury Act of 1986, established a mandatory, federally administered
no-fault claims process for individuals who allege that they were
harmed by the administration of childhood vaccines.

The vaccine compensation fund was created to supposedly ensure an
adequate supply of vaccines, and to stabilize vaccine costs. A small
fee charged on each vaccines funds the program. According to
statistics on the vaccine compensation web site, in fiscal year
2006, a total of $38.2 million has been paid out in cases involving
47 awards.

In what is reported to be one of the largest settlements ever, in
July 2006, a quadriplegic boy was awarded $43.1 million. The case
alleged that now 7-year-old, Mario Rodriguez, became a quadriplegic
after receiving a measles, mumps and rubella vaccine on January. 25,
2000.

Under the guidelines of the vaccine compensation fund program, the
lawsuit was filed against the Department of Health and Human
Services. Kansas City attorney, Leland Dempsey, who represented the
child, told the Kansas City Star: "One unusual aspect of the case is
that Mario is expected to have a normal lifespan, and therefore will
require more years of care that will cost more money."

"He will need round-the-clock care, including extensive medical
intervention, throughout his life," Mr Dempsey said.

Many other vaccine related lawsuits have been filed against drug
makers. For instance, Eli Lilly, the company that invented
thimerosal back in the 1930s, informed its shareholders in its 2005
Annual Report filed with the SEC on April 1, 2006: "We have been
named as a defendant in approximately 340 actions in the U.S.,
involving approximately 1,020 claimants, brought in various state
courts and federal district courts on behalf of children with autism
or other neurological disorders."

Lilly also stated, we believe that "the majority of the cases should
not be prosecuted in the courts in which they have been brought
because the underlying claims are subject to the National Childhood
Vaccine Injury Act of 1986."

Under the Act, claims must first be brought before the US Court of
Claims for an award determination under the guidelines established
by the Act. However, as Lilly points out in its filing, "Claimants
who are unsatisfied with their awards under the Act may reject the
award and seek traditional judicial remedies."

Persons injured by drug companies can get information at
LawyersandSettlements.com.

Evelyn Pringle

[email protected]

(Evelyn Pringle is a columnist for OpEd News and an investigative
journalist focused on exposing corruption in government.)

****
Online Feedback:
Go to URL at top of page; scroll to bottom to enter comments

****TOIL for Lyme****
T = Teach tolerance
0 = Overcome ignorance
I = Initiate insurance reform
L = Labor for Lyme literacy/advocacy

===
The mission of LymeInfo is to keep you informed of issues that might be of interest to Lyme disease patients. Postings are not meant to imply that we agree with the content of all items we distribute.

For Lyme information, see:
http://www.LymeInfo.net

Please tell others how to subscribe to this group:
[email protected]

Posts: 7052 | From Colorado | Registered: Mar 2003  |  IP: Logged | Report this post to a Moderator
Thomas Parkman
LymeNet Contributor
Member # 3669

Icon 1 posted      Profile for Thomas Parkman     Send New Private Message       Edit/Delete Post   Reply With Quote 
Excellent info. You are to be commended for bringing this to the attention of the membership. It proves what I have been saying for years. The CDC and all the federal agencies have been bought and sold by the big medical/drug/insurance interests. Lyme is simply one glaring example of what has happened under the recent political leadership. These decisions and the values or should I say lack of values other than the almightly dollar are a major reason we are in the mess we are in. These issues are ultimately not scientific or medical but political. Cheers.

--------------------
Thomas Parkman

Posts: 341 | From Columbia SC 29206 | Registered: Feb 2003  |  IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is not enabled.
UBB Code� is enabled.

Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | LymeNet home page | Privacy Statement

Powered by UBB.classic™ 6.7.3


The Lyme Disease Network is a non-profit organization funded by individual donations. If you would like to support the Network and the LymeNet system of Web services, please send your donations to:

The Lyme Disease Network of New Jersey
907 Pebble Creek Court, Pennington, NJ 08534 USA


| Flash Discussion | Support Groups | On-Line Library
Legal Resources | Medical Abstracts | Newsletter | Books
Pictures | Site Search | Links | Help/Questions
About LymeNet | Contact Us

© 1993-2020 The Lyme Disease Network of New Jersey, Inc.
All Rights Reserved.
Use of the LymeNet Site is subject to Terms and Conditions.